By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a




Company News
TapImmune Inc. (TPIV) To Present At The Maidstone Life Sciences "Cancer Immunotherapy: A Long-Awaited Reality" On Thursday March 26, 2015 3/25/2015 9:46:54 AM
TapImmune Inc. (TPIV) Appoints David Laskow-Pooley, CEO Of London Pharma, To Its Board Of Directors 3/19/2015 7:10:20 AM
TapImmune Inc. (TPIV) Receives $1,000,000 From Strategic Investor 3/10/2015 7:06:55 AM
TapImmune Inc. (TPIV) Appoints John Bonfiglio As Strategic Advisor 2/25/2015 9:14:09 AM
TapImmune Inc. (TPIV) Appoints Patrick D. Yeramian, MD, Consulting Medical Director To Lead Phase II Clinical Trials In Triple Negative Breast And HER2/neu Breast Cancer 2/23/2015 9:31:23 AM
TapImmune Inc. (TPIV) To Present At The 3rd Annual Sachs Bio Partnering & Investment Forum On February 23, 2015 2/20/2015 1:33:28 PM
TapImmune Inc. (TPIV)'s CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" For Phase II Trials 2/12/2015 12:57:46 PM
TapImmune Inc. (TPIV) Announces $1,464,000 Million Registered Direct Offering 1/12/2015 9:27:40 AM
TapImmune Inc. (TPIV) Release: Positive Phase 1 Immune Responses In All Evaluable Ovarian And Breast Cancer Patients Advances Vaccine To Phase 2 Clinical Trials 1/12/2015 8:50:40 AM
Published Review and Analyst Report Boost TapImmune Inc. (TPIV) Shares 11/20/2014 2:37:19 PM